health
Bring in New and Complementary Expertise
Why this initiative?
GlaxoSmithKline (GSK) is a science-led, global healthcare company that has a significant global presence with commercial operations in more than 150 countries, a network of 84 manufacturing sites in 36 countries and large R&D centers in the UK, USA, Spain, Italy, Belgium and China.
GSK Advanced Technology believes that working with outside organizations gives them the opportunity to benefit from the expertise of researchers whose skill sets are different from and complement their own – and vice versa.
Ultimately GSK believe that this will help them bring new medicines to patients more quickly.
Hence GSK opened an Innovation Gallery on NineSights and launched with NineSigma multiple campaigns to find novel approaches and partners.
Other topics :
Get in touch
NineSigma Europe BV
Koning Leopold I straat 3B-3000 LeuvenBelgium
+32 16 24 42 80
europe@ninesigma.com
USE CASES
You may also like...
Pharmaceutical Industry Innovation: From ‘Core’ to ‘Tr…
The pharmaceutical industry may not have been an early adopter of open innovation (OI), yet it has made significant strides in using OI in recent years. According to research “mo…
Digital Health – US faces affordability and regulation cha…
At NineSigma we have a wide range of resources to give our clients in-depth understanding of the latest disruptive innovation trends. One of these resources is our Open Innovation …
Inside our Work: Healthcare insight
Supporting Healthcare Organisations to Uncover Innovative Solutions Healthcare innovation often comes with high costs as industry experts try to solve challenges. The pandemic cris…
